Table 2.
Results recorded in Birman cats and in cats from other breeds.
| Birman | Other breeds | |
|---|---|---|
| WBC × 103/µLa | 10.2 ± 3.9 (9.3) | 11.8 ± 5.4 (10.3) |
| Neutrophils × 103/µLa | 6.0 ± 3.3 (5.1) | 7.0 ± 3.8 (6.0) |
| Lymphocytes × 103/µLa | 3.5 ± 1.6 (3.3) | 3.6 ± 3.0 (2.9)* |
| Monocytes × 103/µLa | 0.2 ± 0.1 (0.2) | 0.4 ± 0.6 (0.3)* |
| Total proteins (g/dL)b | 7.9 ± 1.1 (7.6) | 7.2 ± 1.2 (7.1)** |
| Albumin (g/dL)b | 4.5 ± 0.9 (4.6) | 4.0 ± 1.3 (4.2)* |
| α1-globulin (g/dL)b | 0.2 ± 0.1 (0.2) | 0.2 ± 0.1 (0.2) |
| α2-globulin (g/dL)b | 0.8 ± 0.3 (0.9) | 0.8 ± 0.3 (0.9) |
| β1-globulin (g/dL)b | 0.5 ± 0.1 (0.5) | 0.5 ± 0.3 (0.5)* |
| β2-globulin (g/dL)b | 0.4 ± 0.2 (0.4) | 0.3 ± 0.3 (0.3)*** |
| γ-globulin (g/dL)b | 1.3 ± 1.0 (1.1) | 1.1 ± 0.7 (1.0) |
| A/G ratiob | 1.5 ± 0.5 (1.5) | 1.5 ± 0.6 (1.4) |
| AGP (mg/ml)c | 0.47 ± 0.33 (0.39) | 0.46 ± 0.21 (0.38) |
| CD5 × 103/µLd | 2.24 ± 1.09 (2.10) | 1.93 ± 1.20 (1.63)* |
| CD4 × 103/µLd | 1.34 ± 0.67 (1.29) | 0.96 ± 0.78 (0.77)*** |
| CD8 × 103/µLd | 0.78 ± 0.43 (0.69) | 0.76 ± 0.52 (0.66) |
| CD21 × 103/µLd | 0.85 ± 0.83 (0.69) | 0.89 ± 0.82 (0.67) |
| CD4/CD8 ratiod | 2.02 ± 1.60 (1.73) | 1.43 ± 0.99 (1.22)*** |
| IL12 pg/mLe | 303.4 ± 168.7 (240.6) | 283.1 ± 140.2 (231.9) |
| IL4 pg/mLe | 36.7 ± 28.1 (31.2) | 58.8 ± 56.3 (38.5)** |
| IL12/4 ratioe | 10.1 ± 6.5 (7.3) | 6.9 ± 4.4 (5.5)*** |
| IFN-γpg/mLf | 115.7 ± 65.1 (99.0) | 103.3 ± 82.7 (76.5)* |
Eosinophils and basophils are not reported since they are not the main effectors of innate or specific immunity.
a
Birman n = 71; Other breeds n = 87.
b
Birman n = 68; Other breeds n = 89.
c
Birman n = 75; Other breeds n = 93.
d
Birman n = 71; Other breeds n = 80.
e
Birman n = 62; Other breeds n = 81.
f
Birman n = 62; Other breeds n = 80.
*
P < 0.05;
**
P < 0.01;
***
P < 0.001.